A Comparison of Respiratory Syncytial Viral Prophylaxis in Multiple Births versus Singletons in the Canadian Registry of Palivizumab.

Bosco A PaesAbby LiDoyoung KimKrista L LanctotIan Mitchellnull null

Published in: American journal of perinatology (2020)

Multiple birth infants, who are known to be at greater risk for severe RSVH compared with singletons, are well protected by palivizumab, provided adherence to the monthly injection scheme is guaranteed.

Keyphrases

respiratory syncytial virus
gestational age
sars cov
early onset
ultrasound guided
type diabetes
metabolic syndrome
glycemic control
insulin resistance
pregnancy outcomes